These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28413973)

  • 1. Docking-Related Survey on Natural-Product-Based New Monoamine Oxidase Inhibitors and Their Therapeutic Potential.
    Dhiman P; Malik N; Khatkar A
    Comb Chem High Throughput Screen; 2017; 20(6):474-491. PubMed ID: 28413973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors.
    Dhiman P; Malik N; Khatkar A
    Curr Neuropharmacol; 2018; 16(6):881-900. PubMed ID: 29189167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors: ten years of docking studies.
    Ferino G; Vilar S; Matos MJ; Uriarte E; Cadoni E
    Curr Top Med Chem; 2012; 12(20):2145-62. PubMed ID: 23231393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New role for crinamine as a potent, safe and selective inhibitor of human monoamine oxidase B: In vitro and in silico pharmacology and modeling.
    Naidoo D; Roy A; Slavětínská LP; Chukwujekwu JC; Gupta S; Van Staden J
    J Ethnopharmacol; 2020 Feb; 248():112305. PubMed ID: 31639490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma.
    Chaurasiya ND; Leon F; Muhammad I; Tekwani BL
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Privileged scaffolds as MAO inhibitors: Retrospect and prospects.
    Tripathi AC; Upadhyay S; Paliwal S; Saraf SK
    Eur J Med Chem; 2018 Feb; 145():445-497. PubMed ID: 29335210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid.
    Baek SC; Ryu HW; Kang MG; Lee H; Park D; Cho ML; Oh SR; Kim H
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2403-2407. PubMed ID: 29925480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Products as Monoamine Oxidase Inhibitors: Potential Agents for Neurological Disorders.
    Agrawal N; Bhardwaj A; Singh S; Goyal A; Gaurav A
    Comb Chem High Throughput Screen; 2024; 27(5):701-714. PubMed ID: 37165491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective MAO-B inhibitors: a lesson from natural products.
    Carradori S; D'Ascenzio M; Chimenti P; Secci D; Bolasco A
    Mol Divers; 2014 Feb; 18(1):219-43. PubMed ID: 24218136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Interactions of
    Chaurasiya ND; Midiwo J; Pandey P; Bwire RN; Doerksen RJ; Muhammad I; Tekwani BL
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33212830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic, Molecular and Computational Aspects of Novel Monoamine Oxidase (MAO) Inhibitors.
    Ramesh M; Dokurugu YM; Thompson MD; Soliman ME
    Comb Chem High Throughput Screen; 2017; 20(6):492-509. PubMed ID: 28294055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors.
    Herraiz T; Chaparro C
    Biochem Biophys Res Commun; 2005 Jan; 326(2):378-86. PubMed ID: 15582589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors.
    Pisani L; Barletta M; Soto-Otero R; Nicolotti O; Mendez-Alvarez E; Catto M; Introcaso A; Stefanachi A; Cellamare S; Altomare C; Carotti A
    J Med Chem; 2013 Mar; 56(6):2651-64. PubMed ID: 23437843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders.
    Dhiman P; Malik N; Sobarzo-Sánchez E; Uriarte E; Khatkar A
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone.
    Lee HW; Ryu HW; Kang MG; Park D; Oh SR; Kim H
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1136-1140. PubMed ID: 28188065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2019; 19(2):133-145. PubMed ID: 31258092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel monoamine oxidase selective inhibitors employing a hierarchical ligand-based virtual screening strategy.
    Wang D; Li Z; Liu Y; Chen M; Chen N; Zuo Z; Kong DX
    Future Med Chem; 2019 Apr; 11(8):801-816. PubMed ID: 31140884
    [No Abstract]   [Full Text] [Related]  

  • 18. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
    Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
    Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review.
    Mathew B; Mathew GE; Petzer JP; Petzer A
    Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scaffold hopping approach to identify novel monoamine oxidase B inhibitors.
    Geldenhuys WJ; Funk MO; Van der Schyf CJ; Carroll RT
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1380-3. PubMed ID: 22225638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.